744 related articles for article (PubMed ID: 33042259)
1. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
2. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-related receptor γ regulates hepatic triglyceride metabolism through phospholipase A2 G12B.
Chen L; Wu M; Zhang S; Tan W; Guan M; Feng L; Chen C; Tao J; Chen L; Qu L
FASEB J; 2019 Jul; 33(7):7942-7952. PubMed ID: 30922124
[TBL] [Abstract][Full Text] [Related]
4. Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression.
Liu Q; Yang M; Fu X; Liu R; Sun C; Pan H; Wong CW; Guan M
Mol Cell Endocrinol; 2016 Nov; 436():93-101. PubMed ID: 27471003
[TBL] [Abstract][Full Text] [Related]
5. Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway.
Li P; Chen X; Dong M; Luo J; Lu S; Chen M; Zhang Y; Zhou H; Jiang H
Free Radic Biol Med; 2021 Aug; 172():459-469. PubMed ID: 34186207
[TBL] [Abstract][Full Text] [Related]
6. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
7. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
9. Divergent Role of Estrogen-Related Receptor α in Lipid- and Fasting-Induced Hepatic Steatosis in Mice.
B'chir W; Dufour CR; Ouellet C; Yan M; Tam IS; Andrzejewski S; Xia H; Nabata K; St-Pierre J; Giguère V
Endocrinology; 2018 May; 159(5):2153-2164. PubMed ID: 29635284
[TBL] [Abstract][Full Text] [Related]
10. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
Cano A; Buqué X; Martínez-Uña M; Aurrekoetxea I; Menor A; García-Rodríguez JL; Lu SC; Martínez-Chantar ML; Mato JM; Ochoa B; Aspichueta P
Hepatology; 2011 Dec; 54(6):1975-86. PubMed ID: 21837751
[TBL] [Abstract][Full Text] [Related]
11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
12. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
[TBL] [Abstract][Full Text] [Related]
13. Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion.
van Zwol W; Rimbert A; Wolters JC; Smit M; Bloks VW; Kloosterhuis NJ; Huijkman NCA; Koster MH; Tharehalli U; de Neck SM; Bournez C; Fuh MM; Kuipers J; Rajan S; de Bruin A; Ginsberg HN; van Westen GJP; Hussain MM; Scheja L; Heeren J; Zimmerman P; van de Sluis B; Kuivenhoven JA
Hepatology; 2023 Nov; 78(5):1418-1432. PubMed ID: 36053190
[TBL] [Abstract][Full Text] [Related]
14. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway.
Zhu X; Xiong T; Liu P; Guo X; Xiao L; Zhou F; Tang Y; Yao P
Food Chem Toxicol; 2018 Apr; 114():52-60. PubMed ID: 29438776
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis.
Chen CY; Li Y; Zeng N; He L; Zhang X; Tu T; Tang Q; Alba M; Mir S; Stiles EX; Hong H; Cadenas E; Stolz AA; Li G; Stiles BL
Am J Pathol; 2021 Jul; 191(7):1240-1254. PubMed ID: 33894178
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
[TBL] [Abstract][Full Text] [Related]
17. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.
Song Y; Zhao M; Cheng X; Shen J; Khound R; Zhang K; Su Q
J Mol Med (Berl); 2017 Aug; 95(8):839-849. PubMed ID: 28455595
[TBL] [Abstract][Full Text] [Related]
18. Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.
Chen Z; Wang S; Pottekat A; Duffey A; Jang I; Chang BH; Cho J; Finck BN; Davidson NO; Kaufman RJ
Mol Metab; 2024 Feb; 80():101874. PubMed ID: 38211723
[TBL] [Abstract][Full Text] [Related]
19. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.
Lee C; Kim J; Han J; Oh D; Kim M; Jeong H; Kim TJ; Kim SW; Kim JN; Seo YS; Suzuki A; Kim JH; Jung Y
Nat Commun; 2022 Jan; 13(1):578. PubMed ID: 35102146
[TBL] [Abstract][Full Text] [Related]
20. ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.
Chen Z; Newberry EP; Norris JY; Xie Y; Luo J; Kennedy SM; Davidson NO
J Lipid Res; 2008 Sep; 49(9):2013-22. PubMed ID: 18519977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
